These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 6310411)

  • 41. Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis.
    Swierkosz JE; Swanborg RH
    J Immunol; 1975 Sep; 115(3):631-3. PubMed ID: 50370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Susceptibility of Lewis rats to experimental autoimmune encephalomyelitis after recovery from passively induced disease.
    Holda JH; Swanborg RH
    Immunol Commun; 1980; 9(4):333-40. PubMed ID: 6157638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coronavirus JHM-induced demyelinating encephalomyelitis in rats: influence of immunity on the course of disease.
    Wege H; Watanabe R; Koga M; Ter Meulen V
    Prog Brain Res; 1983; 59():221-31. PubMed ID: 6320266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
    Jung S; Toyka K; Hartung HP
    Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. JHM infections in rats as a model for acute and subacute demyelinating disease.
    Wege H; Koga M; Wege H; ter Meulen V
    Adv Exp Med Biol; 1981; 142():327-40. PubMed ID: 6278889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of myelin antigens in murine relapsing experimental allergic encephalomyelitis.
    Lublin FD
    J Clin Lab Immunol; 1984 Apr; 13(4):179-82. PubMed ID: 6204053
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preferential distribution of V beta 8.2-positive T cells in the central nervous system of rats with myelin basic protein-induced autoimmune encephalomyelitis.
    Tsuchida M; Matsumoto Y; Hirahara H; Hanawa H; Tomiyama K; Abo T
    Eur J Immunol; 1993 Oct; 23(10):2399-406. PubMed ID: 7691605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Susceptibility and resistance to experimental allergic encephalomyelitis: relationship with hypothalamic-pituitary-adrenocortical axis responsiveness in the rat.
    Stefferl A; Linington C; Holsboer F; Reul JM
    Endocrinology; 1999 Nov; 140(11):4932-8. PubMed ID: 10537116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A.
    Panitch HS; McFarlin DE
    J Immunol; 1977 Sep; 119(3):1134-7. PubMed ID: 302272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats.
    Kawai K; Kobayashi Y; Shiratori M; Sobue G; Tamatani T; Miyasaka M; Yoshikai Y
    Cell Immunol; 1996 Aug; 171(2):262-8. PubMed ID: 8806796
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemorrhagic autoimmune encephalomyelitis induced by adoptive transfer of activated semiallogeneic spleen cells into irradiated rats.
    Matsumoto Y; Kawai K; Fujiwara M
    Am J Pathol; 1988 Nov; 133(2):306-15. PubMed ID: 2461090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats.
    Xiao BG; Huang YM; Yang JS; Xu LY; Link H
    Clin Exp Immunol; 2001 Aug; 125(2):300-9. PubMed ID: 11529923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental autoimmune demyelinating diseases: experimental allergic encephalomyelitis and experimental allergic neuritis.
    Lisak RP; Behan PO
    Biomedicine; 1975 Mar; 22(2):81-7. PubMed ID: 55276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
    Dittel BN
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apoptosis of V beta 8.2+ T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein.
    McCombe PA; Nickson I; Tabi Z; Pender MP
    J Neurol Sci; 1996 Jul; 139(1):1-6. PubMed ID: 8836965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of oral administration of pig spinal cord hydrolysate on clinical and histopathological symptoms of experimental allergic encephalomyelitis in rats.
    Kasarełło K; Gadamski R; Piotrowski P; Kurzepa K; Kwiatkowska-Patzer B; Lipkowski AW
    Folia Neuropathol; 2015; 53(2):128-38. PubMed ID: 26216115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Experimental coronavirus encephalomyelitis in mice].
    Maĭorova LP; Konovalov GV; Ogurtsov RP; Smorodintsev AA
    Vopr Virusol; 1987; 32(1):99-105. PubMed ID: 3033910
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Passive transfer of experimental autoimmune encephalomyelitis in Wistar rats: dissociation of clinical symptoms and biochemical alterations.
    Degano AL; Roth GA
    J Neurosci Res; 2000 Jan; 59(2):283-90. PubMed ID: 10650887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats.
    van der Laan LJ; van der Goes A; Wauben MH; Ruuls SR; Döpp EA; De Groot CJ; Kuijpers TW; Elices MJ; Dijkstra CD
    J Neurosci Res; 2002 Jan; 67(2):191-9. PubMed ID: 11782963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Active immunization with complementary peptide PBM 9-1: preliminary evidence that it modulates experimental allergic encephalomyelitis in PL/J mice and Lewis rats.
    Zhou SR; Whitaker JN
    J Neurosci Res; 1996 Aug; 45(4):439-46. PubMed ID: 8872904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.